RHEUM || Rheumatoid Arthritis | European Federation of Internal Medicine

Guidelines, quality indicators found lacking for CVD in RA

Posted on: 11/08/2014 - 21:30

Rheumatoid arthritis increases cardiovascular risks as much as diabetes does, but guidelines and quality indicators fail to adequately address cardiovascular disease prevention for RA patients,...

Field of Interest: Rheumatology

Type: News Item

Age, income, ethnicity predicted rheumatoid arthritis drug discontinuation

Posted on: 31/07/2014 - 18:25

Some of the same factors that predict patients’ discontinuation of disease-modifying antirheumatic drugs for rheumatoid arthritis also appear to predict their initiation, such as use of oral...

Field of Interest: Rheumatology

Type: News Item

Higher risk of progression found in joints with subclinical joint inflammation on MRI

Posted on: 30/07/2014 - 18:50

The joints of patients with early arthritis that showed subclinical inflammation on MRI had an increased risk of radiographic progression in the first year after disease presentation, particularly...

Field of Interest: Rheumatology

Type: News Item

VIDEO: Does obesity’s effect on RA support different treatment goals?

Posted on: 08/07/2014 - 20:15

PARIS – Treat-to-target goals for obese patients with rheumatoid arthritis should take into account new research indicating that they already have a higher level of systemic inflammation and higher...

Field of Interest: Rheumatology

Type: News Item

Obesity may drive symptom severity in rheumatoid arthritis

Posted on: 07/07/2014 - 16:05

PARIS – The higher disease activity scores seen in obese patients with rheumatoid arthritis may be driven by the proinflammatory state that is associated with obesity, Dr. Christopher Sparks reported...

Field of Interest: Rheumatology

Type: News Item

VIDEO: Sarilumab shows RA safety, efficacy in phase III trial

Posted on: 26/06/2014 - 21:45

PARIS – Treatment with the interleukin-6–blocking drug sarilumab led to statistically significant and clinically meaningful improvements in patients with rheumatoid arthritis in a multicenter,...

Field of Interest: Rheumatology

Type: News Item

Higher risk of death seen with oral steroids in RA interstitial lung disease

Posted on: 19/06/2014 - 18:15

The use of prednisone for 3 or more months at a time was associated with a significantly elevated risk of death in patients with rheumatoid arthritis and interstitial lung disease in a retrospective...

Field of Interest: Rheumatology

Type: News Item

International RA risk tool for CVD comes closer to reality

Posted on: 13/06/2014 - 18:30

An international collaboration of experts has developed a cardiovascular risk calculator specifically for rheumatoid arthritis patients that has the potential to become part of routine rheumatology...

Field of Interest: Rheumatology

Type: News Item

Sarilumab shown safe, effective for RA in phase III trial

Posted on: 13/06/2014 - 16:15

PARIS – Rheumatoid arthritis patients who received the interleukin-6–blocking drug sarilumab plus methotrexate had significantly better short-term and 1-year outcomes than did patients on...

Field of Interest: Rheumatology

Type: News Item

Infliximab biosimilar shown identical over first 16 weeks

Posted on: 11/06/2014 - 21:25

Treatment with infliximab and a biosimilar agent showed virtually identical efficacy and safety performance at several time points during the first 16 weeks of treatment of 189 patients with...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

Latest Newsletters